Sign In
Buy NAOV
$4.02
+0 (+0%)
At Close: Mar 13, 2026
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, announced tod
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
08:00am, Wednesday, 11'th Jun 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through i
NanoVibronix Announces CEO Transition
08:38am, Wednesday, 04'th Jun 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the retire
NanoVibronix Responds to False Post
04:22pm, Wednesday, 28'th May 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) confirmed that a series of posts made earlier today with respect to a $26 million registered direct offering of com
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants
04:30pm, Friday, 16'th May 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the closin
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants
09:00am, Thursday, 15'th May 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the pricin
NanoVibronix Announces Results from UroShield™ Case Series
08:50am, Monday, 12'th May 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in therapeutic devices, today announced findings from a recent retrospec
NanoVibronix Regains Nasdaq Compliance
08:00am, Friday, 11'th Apr 2025
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical technology company specializing in non-invasive therapeutic devices, today annou
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
08:00am, Tuesday, 01'st Apr 2025
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical technology company specializing in non-invasive therapeutic devices, today annou
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that an independe
NanoVibronix Announces Reverse Stock Split
08:00am, Wednesday, 12'th Mar 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announc
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
09:43am, Friday, 14'th Feb 2025
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
08:00am, Monday, 06'th Jan 2025
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SA
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
08:30am, Wednesday, 09'th Oct 2024
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (�
NanoVibronix Signs Letter of Intent with Potential New Distributor
08:30am, Monday, 23'rd Sep 2024
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (S
